MTEM

Molecular Templates (MTEM)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MTEM
DataOraFonteTitoloSimboloCompagnia
15/05/202423:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MTEMMolecular Templates Inc
15/05/202423:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
15/05/202423:11GlobeNewswire Inc.Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
09/04/202414:11GlobeNewswire Inc.Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer PatienNASDAQ:MTEMMolecular Templates Inc
29/03/202413:21GlobeNewswire Inc.Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
28/03/202413:11GlobeNewswire Inc.Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase AgreementNASDAQ:MTEMMolecular Templates Inc
04/03/202414:11GlobeNewswire Inc.Molecular Templates, Inc. Provides Interim UpdateNASDAQ:MTEMMolecular Templates Inc
15/02/202402:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MTEMMolecular Templates Inc
14/02/202422:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MTEMMolecular Templates Inc
08/02/202423:55GlobeNewswire Inc.Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:MTEMMolecular Templates Inc
25/01/202423:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
13/11/202322:11GlobeNewswire Inc.Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/11/202321:11GlobeNewswire Inc.Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid TumorsNASDAQ:MTEMMolecular Templates Inc
01/11/202321:12GlobeNewswire Inc.Molecular Templates to Participate in Upcoming Investor ConferencesNASDAQ:MTEMMolecular Templates Inc
06/10/202323:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
28/09/202322:11GlobeNewswire Inc.Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerNASDAQ:MTEMMolecular Templates Inc
12/09/202323:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MTEMMolecular Templates Inc
12/09/202323:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MTEMMolecular Templates Inc
12/09/202323:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MTEMMolecular Templates Inc
21/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTEMMolecular Templates Inc
11/08/202317:22GlobeNewswire Inc.Molecular Templates Announces 1-for-15 Reverse Stock SplitNASDAQ:MTEMMolecular Templates Inc
10/08/202315:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MTEMMolecular Templates Inc
10/08/202314:08GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/08/202322:11GlobeNewswire Inc.Molecular Templates Announces Executive Leadership ChangesNASDAQ:MTEMMolecular Templates Inc
31/07/202322:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:MTEMMolecular Templates Inc
13/07/202314:14GlobeNewswire Inc.Molecular Templates Announces Up to $40 Million Private Placement OfferingNASDAQ:MTEMMolecular Templates Inc
30/06/202322:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MTEMMolecular Templates Inc
26/06/202323:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MTEMMolecular Templates Inc
20/06/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTEMMolecular Templates Inc
17/06/202302:56GlobeNewswire Inc.Molecular Templates Announces Debt Payoff and RestructuringNASDAQ:MTEMMolecular Templates Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MTEM
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network